-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Edited by Yimaitong, please do not reprint without authorization
.
Looking back at 2021, there is no shortage of harvests from the busy schedule
.
For the field of endocrinology, 2021 is equally fruitful
.
Yimaitong has compiled foreign guidelines/expert consensuses, hoping to be helpful to teachers
.
American Diabetes Association Standards of Care (2022 Edition) On December 21, 2021, the "American Diabetes Association Standards of Care (2022 Edition)" was released on the Diabetes Care website.
The new version of the guidelines generally continues the structure since the 2019-2021 version.
The structural change is that chronic kidney disease is independent from the previous chapter on microvascular disease, and the content is more updated than the 2021 edition, which also reflects the rapid progress in the field of diabetes
.
Related articles: [1] The 2022 version of the "ADA Standards for Diabetes Care" was released, and the new "Drug Selection Roadmap" is here! [2] "DKD New Drugs" first appeared, the "Obesity Drugs" catalogue was updated, and the five major update points of the new ADA guidelines! [3] What changes? Here is the download link for the revised summary of the 2022 edition of the ADA Standards of Diabetes Care: http://guide.
medlive.
cn/guideline/24757 IDF Global Diabetes Map (10th Edition) December 6, 2021, the full version of the 2021 IDF Global The Diabetes Map (10th Edition) was released on the official website of the International Diabetes Federation (IDF)
.
Data show that in 2021, the number of adults with diabetes in the world will reach 537 million (10.
5%), and about 1 in 10 adults will be affected
.
Compared to 2019, there were 74 million more people with diabetes, an increase of 16%, underscoring the alarming increase in the global prevalence of diabetes
.
According to the IDF, the number will reach 783 million by 2045, a 46% increase that is more than double the estimated population growth (20%) over the same period, and could affect one in eight adults
.
Related Article: Diabetes is getting out of control - IDF Global Diabetes Map (10th Edition) Full Release! Download link: https://diabetesatlas.
org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.
pdf 2021 EUGOGO Clinical Practice Guidelines: Pharmacological Treatment of Graves Ophthalmopathy "2021 EUGOGO Clinical Practice Guidelines: Pharmacological Treatment of Graves Ophthalmopathy" in 2016 It has been updated on the basis of the latest version of the guideline, and in particular, new biologics and related studies for the treatment of moderate-to-severe and active GRAVES ophthalmopathy (GO) in recent years have been included
.
It contains a total of 32 recommendations and 4 disease management roadmaps, involving "the evaluation of clinical activity and severity of GO", "recommendation of first- and second-line treatment plans for different degrees of GO" and so on
.
Related articles: [1] The 2021 edition of the European "thyroid eye disease" guideline released! Covering 32 recommendations and 4 management roadmaps [2] 2021 EUGOGO Clinical Guidelines for Thyroid Eye Disease Update Highlights and Interpretation Download link: http://guide.
medlive.
cn/guideline/23761 2021 International Consensus Report: Remission of Type 2 Diabetes Definition and interpretation of the disease With the deepening of the understanding of the disease, the concept of "type 2 diabetes is a lifelong disease" has become outdated
.
On August 30, the "Consensus Report: Definition and Interpretation of Remission of Type 2 Diabetes" drafted by international experts organized by the American Diabetes Association (ADA) was published online in the journal Diabetologia.
The "Consensus" named "Remission of Type 2 Diabetes".
, diagnostic criteria, diagnostic scheme and other aspects, put forward 6 core suggestions, and corrected the misunderstandings in clinical practice
.
Related article: Overturn the concept of "lifelong disease" and put forward a clear definition of "diabetes remission", the expert consensus of the American Diabetes Association is released! Download link: http://guide.
medlive.
cn/guideline/24048 2021 Western Pacific Consensus Recommendations: Management of Prediabetes Prediabetes and the burden of diabetes have become serious challenges in the Western Pacific
.
Impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and risk factors for diabetes in patients with prediabetes
.
This article mainly provides evidence-based consensus recommendations for the management of prediabetes, aiming to provide a simple management approach for the management of these patients
.
Related article: Expert consensus on the management of prediabetes in the Western Pacific Region is out! Download link: http://guide.
medlive.
cn/guideline/22565 Expert consensus on the diagnosis and treatment of patients with hyperuricemia and high cardiovascular risk: 2021 update At the beginning of 2021, the Cardiology Journal published the "On the Diagnosis and Treatment of Hyperuricemia".
Expert consensus on the diagnosis and treatment of patients with uricemia and high cardiovascular risk: 2021 update.
This consensus is an update of the 2018 consensus.
It was jointly formulated by a number of cardiovascular experts from Poland and Italy.
It aims to To provide guidance on the disease management of hyperuricemia (HU) patients with cardiovascular risk
.
Related article: 5-level ladder treatment, the latest foreign "Hyperuricemia Expert Consensus" is here! Download link: http://guide.
medlive.
cn/guideline/22452 2021 ABCD/RA Guidelines: Detection and Management of Post-Organ Transplant Diabetes ) jointly issued guidelines for the detection and management of diabetes after organ transplantation
.
Post-transplant diabetes mellitus (PTDM) is common after solid organ transplantation and is associated with increased morbidity and mortality in allogeneic transplant recipients
.
This article focuses on the detection and management of post-transplant diabetes mellitus, focusing on: epidemiology, pathology, detection, management, adjustment of immunosuppression, prevention, and nonrenal PTDM
.
Download link: http://guide.
medlive.
cn/guideline/22470 2021 Asian Expert Recommendation: Application of sodium-glucose cotransporter 2 inhibitors in Asian patients with type 2 diabetes and kidney disease Early release of type 2 diabetes and high incidence of comorbidities The prevalence and risk of rapid progression of diabetic nephropathy (DKD) are higher in Asian populations
.
In addition to renin-angiotensin system inhibitors, sodium-glucose cotransporter 2 inhibitors have also been shown to delay disease progression in DKD
.
This article mainly focuses on the application of sodium-glucose cotransporter 2 inhibitors in Asian patients with type 2 diabetes and kidney disease, and points out that SGLT-2 inhibitors can delay disease progression in Asian patients with DKD and protect renal function in high-risk patients with kidney disease
.
Download link: http://guide.
medlive.
cn/guideline/227872021 ATA guideline: management of patients with anaplastic thyroid cancer The American Thyroid Association (ATA) has issued guidelines for the management of patients with anaplastic thyroid cancer
.
Anaplastic thyroid cancer is a rare but fatal form of thyroid cancer
.
This article mainly provides guidance and recommendations for the management of patients with anaplastic thyroid cancer, covering diagnosis, initial assessment, treatment methods and monitoring, etc.
It contains a total of 31 recommendations and 16 best practice statements
.
Related articles: Prof.
Su Qing: Interpretation of "Management of Patients with Undifferentiated Thyroid Cancer: 2021 ATA Guidelines" Download link: http://guide.
medlive.
cn/guideline/22913 Asia Pacific Society of Cardiology: Optimizing Cardiovascular Outcomes in Patients with Type 2 Diabetes Consensus statement The number of people with type 2 diabetes has increased considerably in recent decades, with 60% of them coming from Asia
.
The prevalence of cardiovascular disease in patients with type 2 diabetes in Asia Pacific was higher than in Western countries (33.
6%–44.
5% vs 27.
5%–46%)
.
The Asia Pacific Society of Cardiology published a consensus statement on optimizing cardiovascular outcomes in patients with type 2 diabetes, with 13 management recommendations
.
Related article: Type 2 diabetes: 13 recommendations for cardiovascular disease prevention Download link: https://guide.
medlive.
cn/guideline/23222 2021ADA/EASD Consensus Report: Management of Patients with Type 1 Diabetes 2021, American Diabetes Association ( ADA) and the European Association for the Study of Diabetes (EASD) jointly issued a consensus on the management of patients with type 1 diabetes
.
The main content involves the initial evaluation and treatment of patients with type 1 diabetes, the goals of blood glucose management in adults with type 1 diabetes, the general principles of blood glucose management, the management flow chart of suspected type 1 diabetes patients, and the adjuvant treatment options for type 1 diabetes (metformin, general Linlantide, GLP-1RA, SGLT-2i), indications for β-cell replacement therapy, selection of insulin and blood glucose monitoring strategies,
etc.
Related Article: Leading a New Direction in Diabetes Management? The first "Adult Type 1 Diabetes Management: Joint ADA/EASD Consensus" released! Download link: http://guide.
medlive.
cn/guideline/24257 2021 International Consensus Statement: Diagnosis, Multidisciplinary Management and Lifelong Care of Patients with Achondroplasia Various medical, functional, and psychosocial challenges exist across the lifespan
.
This article provides consensus recommendations for the diagnosis, multidisciplinary management, and lifelong care of patients with achondroplasia to facilitate improvement in care and standardization of management for these patients
.
Download link: https://guide.
medlive.
cn/guideline/24595
.
Looking back at 2021, there is no shortage of harvests from the busy schedule
.
For the field of endocrinology, 2021 is equally fruitful
.
Yimaitong has compiled foreign guidelines/expert consensuses, hoping to be helpful to teachers
.
American Diabetes Association Standards of Care (2022 Edition) On December 21, 2021, the "American Diabetes Association Standards of Care (2022 Edition)" was released on the Diabetes Care website.
The new version of the guidelines generally continues the structure since the 2019-2021 version.
The structural change is that chronic kidney disease is independent from the previous chapter on microvascular disease, and the content is more updated than the 2021 edition, which also reflects the rapid progress in the field of diabetes
.
Related articles: [1] The 2022 version of the "ADA Standards for Diabetes Care" was released, and the new "Drug Selection Roadmap" is here! [2] "DKD New Drugs" first appeared, the "Obesity Drugs" catalogue was updated, and the five major update points of the new ADA guidelines! [3] What changes? Here is the download link for the revised summary of the 2022 edition of the ADA Standards of Diabetes Care: http://guide.
medlive.
cn/guideline/24757 IDF Global Diabetes Map (10th Edition) December 6, 2021, the full version of the 2021 IDF Global The Diabetes Map (10th Edition) was released on the official website of the International Diabetes Federation (IDF)
.
Data show that in 2021, the number of adults with diabetes in the world will reach 537 million (10.
5%), and about 1 in 10 adults will be affected
.
Compared to 2019, there were 74 million more people with diabetes, an increase of 16%, underscoring the alarming increase in the global prevalence of diabetes
.
According to the IDF, the number will reach 783 million by 2045, a 46% increase that is more than double the estimated population growth (20%) over the same period, and could affect one in eight adults
.
Related Article: Diabetes is getting out of control - IDF Global Diabetes Map (10th Edition) Full Release! Download link: https://diabetesatlas.
org/idfawp/resource-files/2021/07/IDF_Atlas_10th_Edition_2021.
pdf 2021 EUGOGO Clinical Practice Guidelines: Pharmacological Treatment of Graves Ophthalmopathy "2021 EUGOGO Clinical Practice Guidelines: Pharmacological Treatment of Graves Ophthalmopathy" in 2016 It has been updated on the basis of the latest version of the guideline, and in particular, new biologics and related studies for the treatment of moderate-to-severe and active GRAVES ophthalmopathy (GO) in recent years have been included
.
It contains a total of 32 recommendations and 4 disease management roadmaps, involving "the evaluation of clinical activity and severity of GO", "recommendation of first- and second-line treatment plans for different degrees of GO" and so on
.
Related articles: [1] The 2021 edition of the European "thyroid eye disease" guideline released! Covering 32 recommendations and 4 management roadmaps [2] 2021 EUGOGO Clinical Guidelines for Thyroid Eye Disease Update Highlights and Interpretation Download link: http://guide.
medlive.
cn/guideline/23761 2021 International Consensus Report: Remission of Type 2 Diabetes Definition and interpretation of the disease With the deepening of the understanding of the disease, the concept of "type 2 diabetes is a lifelong disease" has become outdated
.
On August 30, the "Consensus Report: Definition and Interpretation of Remission of Type 2 Diabetes" drafted by international experts organized by the American Diabetes Association (ADA) was published online in the journal Diabetologia.
The "Consensus" named "Remission of Type 2 Diabetes".
, diagnostic criteria, diagnostic scheme and other aspects, put forward 6 core suggestions, and corrected the misunderstandings in clinical practice
.
Related article: Overturn the concept of "lifelong disease" and put forward a clear definition of "diabetes remission", the expert consensus of the American Diabetes Association is released! Download link: http://guide.
medlive.
cn/guideline/24048 2021 Western Pacific Consensus Recommendations: Management of Prediabetes Prediabetes and the burden of diabetes have become serious challenges in the Western Pacific
.
Impaired fasting glucose (IFG), impaired glucose tolerance (IGT), and risk factors for diabetes in patients with prediabetes
.
This article mainly provides evidence-based consensus recommendations for the management of prediabetes, aiming to provide a simple management approach for the management of these patients
.
Related article: Expert consensus on the management of prediabetes in the Western Pacific Region is out! Download link: http://guide.
medlive.
cn/guideline/22565 Expert consensus on the diagnosis and treatment of patients with hyperuricemia and high cardiovascular risk: 2021 update At the beginning of 2021, the Cardiology Journal published the "On the Diagnosis and Treatment of Hyperuricemia".
Expert consensus on the diagnosis and treatment of patients with uricemia and high cardiovascular risk: 2021 update.
This consensus is an update of the 2018 consensus.
It was jointly formulated by a number of cardiovascular experts from Poland and Italy.
It aims to To provide guidance on the disease management of hyperuricemia (HU) patients with cardiovascular risk
.
Related article: 5-level ladder treatment, the latest foreign "Hyperuricemia Expert Consensus" is here! Download link: http://guide.
medlive.
cn/guideline/22452 2021 ABCD/RA Guidelines: Detection and Management of Post-Organ Transplant Diabetes ) jointly issued guidelines for the detection and management of diabetes after organ transplantation
.
Post-transplant diabetes mellitus (PTDM) is common after solid organ transplantation and is associated with increased morbidity and mortality in allogeneic transplant recipients
.
This article focuses on the detection and management of post-transplant diabetes mellitus, focusing on: epidemiology, pathology, detection, management, adjustment of immunosuppression, prevention, and nonrenal PTDM
.
Download link: http://guide.
medlive.
cn/guideline/22470 2021 Asian Expert Recommendation: Application of sodium-glucose cotransporter 2 inhibitors in Asian patients with type 2 diabetes and kidney disease Early release of type 2 diabetes and high incidence of comorbidities The prevalence and risk of rapid progression of diabetic nephropathy (DKD) are higher in Asian populations
.
In addition to renin-angiotensin system inhibitors, sodium-glucose cotransporter 2 inhibitors have also been shown to delay disease progression in DKD
.
This article mainly focuses on the application of sodium-glucose cotransporter 2 inhibitors in Asian patients with type 2 diabetes and kidney disease, and points out that SGLT-2 inhibitors can delay disease progression in Asian patients with DKD and protect renal function in high-risk patients with kidney disease
.
Download link: http://guide.
medlive.
cn/guideline/227872021 ATA guideline: management of patients with anaplastic thyroid cancer The American Thyroid Association (ATA) has issued guidelines for the management of patients with anaplastic thyroid cancer
.
Anaplastic thyroid cancer is a rare but fatal form of thyroid cancer
.
This article mainly provides guidance and recommendations for the management of patients with anaplastic thyroid cancer, covering diagnosis, initial assessment, treatment methods and monitoring, etc.
It contains a total of 31 recommendations and 16 best practice statements
.
Related articles: Prof.
Su Qing: Interpretation of "Management of Patients with Undifferentiated Thyroid Cancer: 2021 ATA Guidelines" Download link: http://guide.
medlive.
cn/guideline/22913 Asia Pacific Society of Cardiology: Optimizing Cardiovascular Outcomes in Patients with Type 2 Diabetes Consensus statement The number of people with type 2 diabetes has increased considerably in recent decades, with 60% of them coming from Asia
.
The prevalence of cardiovascular disease in patients with type 2 diabetes in Asia Pacific was higher than in Western countries (33.
6%–44.
5% vs 27.
5%–46%)
.
The Asia Pacific Society of Cardiology published a consensus statement on optimizing cardiovascular outcomes in patients with type 2 diabetes, with 13 management recommendations
.
Related article: Type 2 diabetes: 13 recommendations for cardiovascular disease prevention Download link: https://guide.
medlive.
cn/guideline/23222 2021ADA/EASD Consensus Report: Management of Patients with Type 1 Diabetes 2021, American Diabetes Association ( ADA) and the European Association for the Study of Diabetes (EASD) jointly issued a consensus on the management of patients with type 1 diabetes
.
The main content involves the initial evaluation and treatment of patients with type 1 diabetes, the goals of blood glucose management in adults with type 1 diabetes, the general principles of blood glucose management, the management flow chart of suspected type 1 diabetes patients, and the adjuvant treatment options for type 1 diabetes (metformin, general Linlantide, GLP-1RA, SGLT-2i), indications for β-cell replacement therapy, selection of insulin and blood glucose monitoring strategies,
etc.
Related Article: Leading a New Direction in Diabetes Management? The first "Adult Type 1 Diabetes Management: Joint ADA/EASD Consensus" released! Download link: http://guide.
medlive.
cn/guideline/24257 2021 International Consensus Statement: Diagnosis, Multidisciplinary Management and Lifelong Care of Patients with Achondroplasia Various medical, functional, and psychosocial challenges exist across the lifespan
.
This article provides consensus recommendations for the diagnosis, multidisciplinary management, and lifelong care of patients with achondroplasia to facilitate improvement in care and standardization of management for these patients
.
Download link: https://guide.
medlive.
cn/guideline/24595
